PARK2 Induces Osteoclastogenesis through Activation of the NF-κB Pathway

Abstract

Osteoclast generation from monocyte/macrophage lineage precursor cells needs to be tightly regulated to maintain bone homeostasis and is frequently over-activated in inflammatory conditions. PARK2, a protein associated with Parkinson's disease, plays an important role in mitophagy via its ubiquitin ligase function. In this study, we investigated whether PARK2 is involved in osteoclastogenesis. PARK2 expression was found to be increased during the receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast differentiation. PARK2 gene silencing with siRNA significantly reduced osteoclastogenesis induced by RANKL, LPS (lipopolysaccharide), TNFα (tumor necrosis factor α), and IL-1β (interleukin-1β). On the other hand, overexpression of PARK2 promoted osteoclastogenesis. This regulation of osteoclastogenesis by PARK2 was mediated by IKK (inhibitory κB kinase) and NF-κB activation while MAPK (mitogenactivated protein kinases) activation was not involved. Additionally, administration of PARK2 siRNA significantly reduced osteoclastogenesis and bone loss in an in vivo model of inflammatory bone erosion. Taken together, this study establishes a novel role for PARK2 as a positive regulator in osteoclast differentiation and inflammatory bone destruction.

Diabetic Rats Induced Using a High-Fat Diet and Low-Dose Streptozotocin Treatment Exhibit Gut Microbiota Dysbiosis and Osteoporotic Bone Pathologies

“…The concept of this axis suggests that dietary bioactives (such as dietary lipids, polysaccharides, polyphenol, vitamins, and metals) may support and maintain the balance of probiotics, and subsequently, their metabolites, such as short-chain fatty acids and bile acids, could further regulate the immune system [ 59 ]. This immunomodulatory property could potentially ameliorate the development of bone diseases, such as osteoarthritis (by inhibiting chondrocyte inflammation) and osteoporosis (by remodeling/rebalancing osteoblast and osteoclast activity) [ 59 , 60 , 61 , 62 ]. Moreover, the gut microbiota plays a critical role in regulating intestinal calcium absorption and vitamin D metabolism, essential for mitochondrial quality control (metabolic homeostasis), macrophage polarization (immunomodulation), and bone cell mineralization [ 59 , 61 , 62 , 63 ].…”

A computational approach based on weighted gene co-expression network analysis for biomarkers analysis of Parkinson’s disease and construction of diagnostic model

“…They were myeloid cell differentiation, cytokine mediated signaling pathway, actin binding, and osteoclast differentiation. Among them, studies on osteoclasts and PD have increased in recent years ( Malik et al, 2021 ; Hong et al, 2022 ), which indicates that osteoclasts may be a new research direction for Parkinson’s mechanism or peripheral biomarkers.…”

Avenanthramide-C Shows Potential to Alleviate Gingival Inflammation and Alveolar Bone Loss in Experimental Periodontitis

“…It is known that the NF-κB and MAPK signaling pathways are associated with the regulation of inflammatory cytokines and MMP genes in periodontal disease. In particular, NF-κB is detected in various signaling targets that correlate with inflammatory processes affecting the gingiva and alveolar bone supporting the teeth ( Guan et al, 2022 ; Hong et al, 2022 ; Song et al, 2021 ). The MAPK family consists of three main subfamilies, namely, ERK-1/-2, JNK, and p38.…”